These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 8502472

  • 21. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE, Lieberman R, Sandlund J, Kiwanuka J, Novikovs L, Kirsch I, Hollis G, Magrath IT.
    Cancer Res; 1989 Jun 15; 49(12):3235-41. PubMed ID: 2497974
    [Abstract] [Full Text] [Related]

  • 22. Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.
    Chang Y, Spicer DB, Sonenshein GE.
    Oncogene; 1991 Nov 15; 6(11):1979-82. PubMed ID: 1682864
    [Abstract] [Full Text] [Related]

  • 23. The mechanism of inactivation of the normal c-myc gene locus in human Burkitt lymphoma cells.
    Nishikura K, Murray JM.
    Oncogene; 1988 May 15; 2(5):493-8. PubMed ID: 3131718
    [Abstract] [Full Text] [Related]

  • 24. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H, Heckman CA, Boxer LM.
    Oncogene; 2007 Apr 19; 26(18):2635-41. PubMed ID: 17043638
    [Abstract] [Full Text] [Related]

  • 25. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM.
    J Biol Chem; 2000 Oct 13; 275(41):32338-46. PubMed ID: 10931834
    [Abstract] [Full Text] [Related]

  • 26. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M, Neuberger MS.
    Oncogene; 2000 Jul 13; 19(30):3404-10. PubMed ID: 10918597
    [Abstract] [Full Text] [Related]

  • 27. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
    Geltinger C, Hörtnagel K, Polack A.
    Gene Expr; 1996 Jul 13; 6(2):113-27. PubMed ID: 8979089
    [Abstract] [Full Text] [Related]

  • 28. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
    Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J.
    Med Sci Monit; 2003 Jan 13; 9(1):HY1-9. PubMed ID: 12552250
    [Abstract] [Full Text] [Related]

  • 29. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.
    Spencer CA, LeStrange RC, Novak U, Hayward WS, Groudine M.
    Genes Dev; 1990 Jan 13; 4(1):75-88. PubMed ID: 2307371
    [Abstract] [Full Text] [Related]

  • 30. Analysis of c-myc expression in a human hepatoma cell line.
    Huber BE, Thorgeirsson SS.
    Cancer Res; 1987 Jul 01; 47(13):3414-20. PubMed ID: 3034414
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc.
    Boffa LC, Cutrona G, Cilli M, Matis S, Damonte G, Mariani MR, Millo E, Moroni M, Roncella S, Fedeli F, Ferrarini M.
    Cancer Gene Ther; 2007 Feb 01; 14(2):220-6. PubMed ID: 17053816
    [Abstract] [Full Text] [Related]

  • 32. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
    Ishida S, Shudo K, Takada S, Koike K.
    Cell Growth Differ; 1994 Mar 01; 5(3):287-94. PubMed ID: 8018561
    [Abstract] [Full Text] [Related]

  • 33. c-myc Suppression in Burkitt's lymphoma cells.
    Simonsson T, Henriksson M.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):11-5. PubMed ID: 11779125
    [Abstract] [Full Text] [Related]

  • 34. The c-myc promoter: still MysterY and challenge.
    Wierstra I, Alves J.
    Adv Cancer Res; 2008 Jan 11; 99():113-333. PubMed ID: 18037408
    [Abstract] [Full Text] [Related]

  • 35. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
    Wilda M, Busch K, Klose I, Keller T, Woessmann W, Kreuder J, Harbott J, Borkhardt A.
    Genes Chromosomes Cancer; 2004 Oct 11; 41(2):178-82. PubMed ID: 15287031
    [Abstract] [Full Text] [Related]

  • 36. Oncogene expression and immunoglobulin synthesis in a North American Burkitt (NAB-2) lymphoma cell line with a 8;22 chromosome translocation.
    Popescu NC, Dahlberg JE, Ablashi DV, Monastier M, Bona CA, DiPaolo JA, Hooper WC, Swan DC.
    Oncogene Res; 1990 Oct 11; 5(4):295-303. PubMed ID: 1697668
    [Abstract] [Full Text] [Related]

  • 37. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kühn M, Lenze D, Lichter P, Martin-Subero JI, Möller P, Müller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Stürzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trümper L, Stein H, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe.
    N Engl J Med; 2006 Jun 08; 354(23):2419-30. PubMed ID: 16760442
    [Abstract] [Full Text] [Related]

  • 38. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
    Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I.
    Nat Genet; 1993 Sep 08; 5(1):56-61. PubMed ID: 8220424
    [Abstract] [Full Text] [Related]

  • 39. Rearrangement of the c-myc oncogene with heavy-chain immunoglobulin enhancer in tumor DNA from an acute lymphoblastic leukemia patient.
    Guerrasio A, Avanzi GC, Pegoraro L, Estivill X, Serra A, Giubellino MC, Fierro MT, Novarino A, Foa R, Saglio G.
    J Natl Cancer Inst; 1987 May 08; 78(5):845-51. PubMed ID: 3106693
    [Abstract] [Full Text] [Related]

  • 40. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S.
    Cancer Res; 2005 Feb 15; 65(4):1306-15. PubMed ID: 15735016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.